Literature DB >> 15964390

Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature.

B J Alkofer1, L Chiche, A Khayat, J P Deshayes, A Lepage, E Saloux, Y Reznik.   

Abstract

Familial hypercholesterolemia (FH) is a dominant inherited disease of low-density lipoprotein (LDL) metabolism caused by mutations of LDL receptors mainly located in the liver. This metabolic disorder is responsible for severe cardiovascular disease, from coronary lesions to chronic heart failure (CHF). Liver transplantation in homozygous FH provides the missing functional LDL receptors and thus partially restores LDL receptor activity to more than 50% of normal. Combined heart and liver transplantation was successfully performed in a homozygous FH patient with end-stage heart failure. Herein we report our experience with a heterozygous male patient with terminal CHF, and review data from the literature on short- and long-term results of such procedures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964390     DOI: 10.1016/j.transproceed.2005.03.037

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively.

Authors:  Michael Ibrahim; Ismail El-Hamamsy; Mahmoud Barbir; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2011-09-01       Impact factor: 4.132

Review 2.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

Review 3.  Combined heart-liver transplantation: Indications, outcomes and current experience.

Authors:  Eliza W Beal; Khalid Mumtaz; Don Hayes; Bryan A Whitson; Sylvester M Black
Journal:  Transplant Rev (Orlando)       Date:  2016-07-17       Impact factor: 3.943

Review 4.  Optimal management of familial hypercholesterolemia: treatment and management strategies.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh
Journal:  Vasc Health Risk Manag       Date:  2010-12-03

5.  LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.

Authors:  Christine L H Snozek; Susan A Lagerstedt; Teck K Khoo; Melvyn Rubenfire; William L Isley; Laura J Train; Linnea M Baudhuin
Journal:  Eur J Hum Genet       Date:  2008-07-23       Impact factor: 4.246

Review 6.  The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Behrooz Astaneh; Nima Makhdami; Vala Astaneh; Gordon Guyatt
Journal:  J Cardiovasc Dev Dis       Date:  2021-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.